Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ROCHE HOLDING LTD.
01:01p ROCHE : Genentech to Open the Next Annual Lyophilization Industry Summit
06/27 ROCHE HOLDING LTD. : Khang & Khang LLP Announces Securities Class Action Lawsuit..
06/27 INDUSTRY NEWS : Roche's Emicizumab Showed Positive Results in Phase III Studies ..
06/27 FEWER PILLS, MORE FLEXIBILITY IN DOS : Roche's new Esbriet tablet formulation ap..
06/27 ROCHE : Invitation to Roche's Half Year Results 2017, Thursday 27th July 2017 - ..
06/27 FEWER PILLS, MORE FLEXIBILITY IN DOS : Roche’s new Esbriet tablet formulat..
06/27 ROCHE : FDA approves drug for blood cancers that's easier to use
06/26 ROCHE HOLDING LTD. : Lundin Law PC Announces Securities Class Action Lawsuit aga..
06/26 ROCHE : emicizumab showed positive results in phase III studies (HAVEN 1 and HAV..
06/26 GENENTECH : ’s Emicizumab Showed Positive Results in Phase III Studies (HA..
06/24 ROCHE HOLDING LTD. : Khang & Khang LLP Announces Securities Class Action Lawsuit..
06/23 ANALOG DEVICES : Global Nano Biosensors Sales Market 2017 - Analog Devices, Robe..
06/23 ROCHE : Why competition is key to cutting the cost of cancer drugs in South Afri..
06/23 ROCHE : The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf o..
06/23 ROCHE : New data at EAN show Roche's OCREVUS (ocrelizumab) significantly reduced..
06/23 ROCHE : Why Competition Is Key to Cutting the Cost of Cancer Drugs in South Afri..
06/23 ROCHE : New data at EAN show Roche’s OCREVUS (ocrelizumab) significantly r..
06/23 IONIS PHARMACEUTICALS : Enrollment in Phase 1/2a Study of IONIS-HTT Rx in Patien..
06/23 ROCHE : Kadcyla to get routine NHS funding after deal with Roche
06/23 ROCHE : Presentation confirms Venclexta/Venclyxto monotherapy benefit in certain..
06/23 ROCHE : presents new data from GALLIUM study reinforcing clinical benefit of Gaz..
06/23 ROCHE : New data at EAN show Roche’s OCREVUS™ (ocrelizumab) signific..
06/23 ROCHE : New Data at EAN Show Genentech’s Ocrevus (Ocrelizumab) Significant..
06/23 ROCHE : The price of life
06/22 ROCHE : FDA approves quicker-to-administer drug for blood cancers
06/22 Levi & Korsinsky, LLP Reminds Investors of the Commencement of an Investigati..
06/22 ROCHE HOLDING LTD. : Lundin Law PC Announces Securities Class Action Lawsuit aga..
06/22 ROCHE : FDA Approves RITUXAN HYCELA (Rituximab and Hyaluronidase Human) for Subc..
06/22 THE KLEIN LAW FIRM : Announces a Class Action Filed on Behalf of Roche Holding A..
06/22 ROCHE HOLDING LTD. : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Cl..
06/22 ROCHE : Novartis` longer-acting AMD drug matches archrival Eylea in phase 3 tria..
06/22 R&D COSTS GROWING, ROCHE SHINES AND : Its the EP report
06/22 ROCHE : Bishop Canevin grad quickly adjusts
06/22 ROCHE HOLDING LTD. : Pawar Law Group Announces Filing of Securities Class Action..
06/22 ROCHE : DNA Sequencing Market 2017 - BGI, Roche, ZiXin, Da Rui, Adicon, Illumina..
06/21 ROCHE HOLDING LTD. : Khang & Khang LLP Announces Securities Class Action Lawsuit..
06/21 FOUNDATION MEDICINE, INC. : Change in Directors or Principal Officers, Submissio..
06/21 ROCHE : HEALTH Cancer drug now available
06/20 Novartis eye drug works with fewer injections than rival
06/20 RHHBY The Law Offices of Vincent Wong Notifies Investors of Commencement of a..
06/20 ROCHE HOLDING LTD. : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Cl..
06/20 SELECTA BIOSCIENCES : SELB) Appoints Patrick Zenner to Board
06/20 ROCHE : Breast cancer drug approved for use in Wales
06/20 U.S. MARKET ADVISORS LAW GROUP PLLC : Alerts Investors of Approaching Lead Plain..
06/19 ROCHE HOLDING LTD. : Khang & Khang LLP Announces Securities Class Action Lawsuit..
06/19 PROTEINASE K MARKET : Merck, Roche, Qiagen, Thermo Fisher Scientific - Segment, ..
06/19 Levi & Korsinsky, LLP Reminds Shareholders of Roche Holding AG of a Class Act..
06/19 ROCHE : Restructuring and extension of the Andr stadium Roche 12, rue Larmeroux ..
06/17 ROCHE : Federal Contracts Awarded to Companies in Indiana (June 17)
06/17 ROCHE : Breast cancer drug approved for NHS England
06/17 ROCHE : Major u-turn sees Roches Kadcyla backed for NHS use
06/17 ROCHE : NICE relents on Kadcyla after Roche pricing negotiations
06/17 ROCHE HOLDING LTD. : Lundin Law PC Announces Securities Class Action Lawsuit aga..
06/17 CANCER DRUG : Apex allows cipla to withdraw plea against swiss major roche
06/16 Levi & Korsinsky, LLP Notifies Shareholders of Roche Holding AG of a Class Ac..
06/16 ROCHE HOLDING LTD. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Noti..
06/16 ROCHE : S/Africa probes multinationals for overpricing drugs
06/16 ROCHE : Advanced breast cancer drug to become routinely available
06/16 ROCHE : Breast cancer wonder drug to become available on the NHS
06/16 ROCHE : Cancer drug approved
06/16 PFIZER : Cancer-drugs probe to go ahead
06/16 Aspen loses Italy appeal over cancer drug prices
06/16 ROCHE : $185.28 Million Federal Contract Awarded to Roche Diagnostics
06/15 FOUNDATION MEDICINE : to Identify Patients Eligible for National Cancer Institut..
06/15 Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit aga..
06/15 ROCHE HOLDING LTD. : Khang & Khang LLP Announces Securities Class Action Lawsuit..
06/15 FOUNDATION MEDICINE : NCI-MATCH cancer trial reaches 6,000-patient tumor sequenc..
06/15 Khang & Khang LLP Announces Securities Class Action Lawsuit Against Roche Hol..
06/15 COMPANY Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceedi..
06/15 ROCHE : Glancy Prongay & Murray LLP Commences Investigation on Behalf of Roche H..
06/15 FOUNDATION MEDICINE : ASCO and Foundation Medicine Announce Collaboration to Hel..
06/15 CHUGAI PHARMACEUTICAL : Data of Chugai's Alecensa® Presented at the American Soc..
06/15 THE KLEIN LAW FIRM : Reminds Investors of an Investigation Concerning Possible V..
06/15 Cancer drug price increases within allowable limits, says Aspen
06/15 ROCHE : Award Notice - Roche Diagnostics Corporation (Cobas 8100) VA/FSS Contrac..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ( CHF)
Sales 2017 53 370 M
EBIT 2017 18 213 M
Net income 2017 11 446 M
Debt 2017 8 981 M
Yield 2017 3,40%
P/E ratio 2017 18,34
P/E ratio 2018 16,93
EV / Sales 2017 4,21x
EV / Sales 2018 3,93x
Capitalization 215 643 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 283  CHF
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Alan Hippe Chief Financial & Information Technology Officer
John Irving Bell Non-Executive Director
Andreas Oeri Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.224 549
JOHNSON & JOHNSON18.34%363 694
ROCHE HOLDING LTD.8.21%224 549
NOVARTIS12.55%222 848
PFIZER3.97%201 105
MERCK AND COMPANY11.33%179 263
More Results